Navigation Links
The GADA Group Ltd. ("GADA") Welcomes its new Shareholder, RBS Equity Finance ("RBEF")
Date:7/1/2011

LONDON, July 1, 2011 /PRNewswire/ --


 

GADA, one of the leading European healthcare distributors and providers of specialized services for public and private hospital facilities in Italy, Romania and Turkey, is proud to announce an investment by new shareholder RBEF.

GADA supplies a broad range of integrated services to public and private healthcare facilities, including the distribution of high-tech medical devices and disposables, clinical and maintenance services, and was incorporated in Italy in the late 1970s. Today the company is a unique and easily scalable platform, with multi-regional distribution from 2009, following the acquisition of a leading Romanian distributor and entry into Turkey.

During the past 5 years, GADA has doubled its revenues and consistently strengthened its balance sheet. In particular, an intensive consolidation project has been commenced, positioning GADA for the next stage of its pan-European expansion plan.

RBEF is investing significant equity to support GADA's expansion in existing operating countries and to finance further acquisitions across Central and Eastern Europe. RBEF's funding and significant experience will support continuing improvements to the existing offering and accelerate growth through further selective acquisitions.

Sante Giovanni Albonetti, CEO of the GADA Group, said of the investment: "GADA has achieved a number of important milestones during the past decade and this success is paying off, as evidenced by the arrival of an important institutional partner. We are very enthusiastic about the entry of RBEF into the shareholder group and look forward to working together to deliver the next phase of our expansion plan. This investment marks an excellent result for the company and will greatly benefit our current and future associates, suppliers and customers."

Andrew Lawley, Managing Director of RBS Equity Finance, added: "Gada is a leading European medical technology distributor with an exceptional range of opportunities to pursue. We are extremely pleased to have made this investment and look forward to actively support the company in delivering its organic and acquisition plans."

About The GADA Group:

GADA is a leading pan-European supplier of integrated services to public and private healthcare facilities in Italy, Romania and Turkey. Its headquarters are located in London, UK.

http://www.gadagroup.com

About RBS Equity Finance:

RBS Equity Finance manages the RBS Special Opportunities Fund, a £1.1bn fund with a broad investment mandate, covering everything from majority equity investment through to mezzanine debt. This makes them an excellent partner for high quality, growth-focused businesses, as well as a provider of M&A expertise and capital in acquisition-led growth scenarios. RBS Special Opportunities Fund currently backs over 20 companies across a variety of sectors and has a strong track record in a range of sectors. http://www.am.rbs.com

 


For further information, please contact:

The GADA Group

Daniel J. Novacek, Tel: +44-7912-514-029

For media enquiries call Alex Simmons, Smithfield, +44-20-7360-4900

RBS Equity Finance

Andrew Lawley, Tel +44-20-7085-8364


'/>"/>
SOURCE The Gada Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OM Group Announces Retirement Plans of Chief Financial Officer Kenneth Haber
2. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
3. Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products
4. ANF Group, Inc. Completes New Joe DiMaggio Childrens Hospital
5. Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies
6. Nolan Law Group: Jury Finds Against Baxter Healthcare In Nations First Contaminated Chinese Heparin Case
7. Assured Pharmacy Engages The Investor Relations Group
8. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
9. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , March 30, 2017  Purcell Julie & Lefkowitz LLP, ... is investigating a potential breach of fiduciary duty claim involving ... SGYP ). If you are a ... information regarding this investigation, free of charge, please visit us ... ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... chromatograph market to grow at a CAGR of 5.20% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:3/29/2017)... -- Research and Markets has announced the addition of the ... Forecast" report to their offering. ... Proton Therapy Market in Italy will ... There are currently three proton therapy centers in Italy ... Italy , the first patients were treated with proton ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... 2017 , ... This morning, more than 275 medical doctors, ... for an independent Vaccine Safety Commission. Five of the signers of the letter, ... a press conference at 9:00 AM Friday, March 31 at the National ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based dog services provider, ... that assists dog owners in creating legally-enforceable pet trusts for their canine companions. ... next step to protect their new companion. Says Evan Dunbar, CEO of Full Contact ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear ... which retails normally at $29.97; for the remaining days of March, the price will ... reduced to a special price of just $10 (regular retail price $19.97). , The ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving quick ... Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is valued ... on each patient’s case, treatment with the FASTBRACES system could be completed in ...
(Date:3/29/2017)... ... ... Curio Wellness , a premium medical cannabis brand and trusted healthcare partner ... with prominent executives from both inside and outside the cannabis industry. , Joining ... , who has more than twenty years of business leadership and investment experience in ...
Breaking Medicine News(10 mins):